BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11891025)

  • 1. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.
    Wu Yl; Huang ZF; Wang SY; Yang XN; Ou W
    Lung Cancer; 2002 Apr; 36(1):1-6. PubMed ID: 11891025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomized clinical trial].
    Wu Y; Wang S; Huang Z
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):43-5. PubMed ID: 11783068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.
    Zhao Y; Mao Y; He J; Gao S; Zhang Z; Ding N; Xue Q; Gao Y; Wang D; Zhao J; Tan F; Yuan L; Li F; Wang S; Yang L
    Clin Lung Cancer; 2021 Mar; 22(2):e201-e210. PubMed ID: 33187913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer.
    Maniwa T; Okumura T; Isaka M; Nakagawa K; Ohde Y; Kondo H
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e59-64. PubMed ID: 23644712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.
    Hishida T; Miyaoka E; Yokoi K; Tsuboi M; Asamura H; Kiura K; Takahashi K; Dosaka-Akita H; Kobayashi H; Date H; Tada H; Okumura M; Yoshino I;
    J Thorac Oncol; 2016 Sep; 11(9):1529-37. PubMed ID: 27249959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediastinal lymph node dissection affects survival in patients with stage I non-small cell lung cancer.
    Su X; Wang X; Long H; Fu J; Lin P; Zhang L; Wang S; Rong T
    Thorac Cardiovasc Surg; 2008 Jun; 56(4):226-30. PubMed ID: 18481243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
    David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
    Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.